Cubist Systematic Strategies, LLC Arvinas, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $1.94 Million - $2.78 Million	53,203 New	53,203 $2.2 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $1.84 Million - $2.65 Million	93,799 Added 95.63%	191,883 $3.77 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $138,420 - $200,209	6,370 Added 6.95%	98,084 $2.43 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $1.39 Million - $1.98 Million	53,051 Added 137.21%	91,714 $2.51 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $1.11 Million - $1.95 Million	-34,129 Reduced 46.89%	38,663 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $776,604 - $1.08 Million	-18,548 Reduced 20.31%	72,792 $3.24 Million
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $2.4 Million - $4.95 Million	66,691 Added 270.56%	91,340 $3.85 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $258,558 - $349,935	4,290 Added 21.07%	24,649 $1.66 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $116,752 - $170,580	1,773 Added 9.54%	20,359 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $227,798 - $335,691	-3,112 Reduced 14.34%	18,586 $1.53 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $1.07 Million - $1.5 Million	-17,767 Reduced 45.02%	21,698 $1.67 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $1.21 Million - $1.9 Million	20,795 Added 111.38%	39,465 $2.61 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $1.23 Million - $5.17 Million	-60,911 Reduced 76.54%	18,670 $1.59 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $1.29 Million - $2.04 Million	56,147 Added 239.6%	79,581 $1.88 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $426,297 - $809,509	14,267 Added 155.63%	23,434 $786,000
Q1 2020 May 15, 2020	SELL	$33.0 - $54.5 $700,986 - $1.16 Million	-21,242 Reduced 69.85%	9,167 $369,000
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $436,275 - $1.26 Million	28,348 Added 1375.45%	30,409 $1.25 Million
Q3 2019 Nov 14, 2019	BUY	$21.55 - $27.61 $44,414 - $56,904	2,061 New	2,061 $44,000
Q2 2019 Aug 14, 2019	SELL	$15.96 - $23.8 $31,935 - $47,623	-2,001 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.55 - $23.79 $27,113 - $47,603	2,001 New	2,001 $30,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

Vanguard Group Inc Valley Forge, PA

7.01M
Shares

$134 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$128 Million
7.19% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$119 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.85M
Shares

$73.5 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

2.78M
Shares

$53.1 Million
1.09% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account